Testing effectiveness (Phase 2)Looking for participantsNCT06277154
What this trial is testing
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Who this might be right for
LeiomyosarcomaLiposarcomaSynovial Sarcoma+8 more
HRYZ Biotech Co. 148